Q4 2025 13F Holders as of 31 Dec 2025
-
Type / Class
-
Equity / SPONSORED ADR
-
Total 13F shares
-
397,598,977
-
Share change
-
+11,038,869
-
Total reported value
-
$19,500,076,620
-
Put/Call ratio
-
37%
-
Price per share
-
$49.04
-
Number of holders
-
966
-
Value change
-
+$561,747,707
-
Number of buys
-
420
-
Number of sells
-
395
Institutional Holders of GSK plc - SPONSORED ADR (GSK) as of Q4 2025
As of 31 Dec 2025,
GSK plc - SPONSORED ADR (GSK) was held by
966 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
397,598,977 shares.
The largest 10 holders included
Dodge & Cox, FMR LLC, Fisher Asset Management, LLC, PRIMECAP MANAGEMENT CO/CA/, JTC Employer Solutions Trustee Ltd, WELLINGTON MANAGEMENT GROUP LLP, ACADIAN ASSET MANAGEMENT LLC, ROYAL BANK OF CANADA, Holocene Advisors, LP, and PRICE T ROWE ASSOCIATES INC /MD/.
This page lists
966
institutional shareholders reporting positions in this security
for the Q4 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.